An abstract written by Georgia Cancer Specialists physician Dr. Rodolfo Bordoni has been chosen for publication in the American Society of Clinical Oncology’s Proceedings at their 2004 annual meeting, ASCO announced recently. The meeting will be held June 5-8 in New Orleans, Louisiana.
Dr. Bordoni, GCS’ Director for Professional Education, said, “To have my abstract chosen among 3,700 others is a nice honor. ASCO puts on a great meeting every year and I look forward to participating once again.”
Dr. Bordoni’s abstract is titled “Multicenter, Prospective, Randomized, Phase-II Trial of Sequential and Concurrent Oral Bexarotene (Targretin) in Combination with Chemotherapy, in Previously Untreated Patients with Advanced NSCLC (non-small cell lung cancer).” Each abstract submitted is thoroughly reviewed by the Scientific Program Committee and ASCO Leadership.
According to their website, ASCO is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s membership is comprised of clinical oncologists representing all oncology disciplines and subspecialties; physicians and health care professionals participating in approved oncology training programs; oncology nurses; and other health care practitioners with a predominant interest in oncology.
The ASCO Annual Meeting is the premier oncology educational and scientific event. Oncologists from all disciplines gather to present and share studies, findings, and new treatments and procedures. The 2003 Meeting in Chicago attracted 26,400 attendees from all over the world.
Dr. Bordoni practices at the GCS Kennestone office.